Literature DB >> 12562871

Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease.

Raul D Santos1, Whady Hueb, Antonio A Oliveira, Jose A F Ramires, Raul C Maranhão.   

Abstract

A cholesterol-rich emulsion (LDE) that resembles the LDL lipidic structure is taken-up by LDL receptors after intravenous injection by means of apolipoprotein E it acquires in the circulation and can be used to probe LDL metabolism. In this study, LDE was labeled with [14C]cholesteryl oleate and [3H]cholesterol and injected into 19 patients with coronary artery disease (CAD) and into 14 subjects without CAD to verify whether the kinetic behavior of the radioactive lipids is different in CAD. Blood was sampled over 24 h for radioactivity measurement after lipid extraction and separation by thin-layer chromatography. Fractional clearance rate (FCR, in h-1) of [14C]cholesteryl ester was not different in CAD and nonCAD expressed as median (25%; 75%): 0.08 (0.062; 0.134) h-1 versus 0.06 (0.04; 0.083) h-1, P = 0.167. However, [3H]cholesterol FCR was greater in CAD than in nonCAD (mean +/- SEM): 0.163 +/- 0.016 h-1 versus 0.077 +/- 0.014 h-1, P < 0.001. Esterification of the LDE [3H]cholesterol was also greater in CAD subjects than nonCAD at 10 h and 24 h after emulsion injection (P = 0.029 and 0.024 respectively). In conclusion, both removal from the plasma and esterification of the LDE-cholesterol were increased in CAD. These findings may contribute for unraveling pro-atherogenic mechanisms and the establishment of novel CAD markers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12562871     DOI: 10.1194/jlr.M200331-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin.

Authors:  Raul D Santos; Ana P M Chacra; Aleksandra Morikawa; Carmen C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

2.  Cholesterol improves the utilization of parenteral lipid emulsions.

Authors:  Wilfred Druml; Margot Fischer
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

3.  Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis.

Authors:  Ricardo D Couto; Luís A O Dallan; Luiz A F Lisboa; Carlos H Mesquita; Carmen G C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2007-04-19       Impact factor: 1.880

4.  Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients.

Authors:  Carolina P Oliveira; Raul C Maranhão; Marina P Bertato; Bernardo L Wajchenberg; Antonio C Lerario
Journal:  Lipids Health Dis       Date:  2012-06-07       Impact factor: 3.876

5.  Plasma kinetics of an LDL-like nanoemulsion and lipid transfer to HDL in subjects with glucose intolerance.

Authors:  Marina P Bertato; Carolina P Oliveira; Bernardo L Wajchenberg; Antonio C Lerario; Raul C Maranhão
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-04

7.  Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-06

8.  Identifying Metabolomic Profiles of Insulinemic Dietary Patterns.

Authors:  Fred K Tabung; Raji Balasubramanian; Liming Liang; Steven K Clinton; Elizabeth M Cespedes Feliciano; JoAnn E Manson; Linda Van Horn; Jean Wactawski-Wende; Clary B Clish; Edward L Giovannucci; Kathryn M Rexrode
Journal:  Metabolites       Date:  2019-06-24

9.  Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.

Authors:  Alina C R Feitosa; Gilson S Feitosa-Filho; Fatima R Freitas; Bernardo L Wajchenberg; Raul C Maranhão
Journal:  Lipids Health Dis       Date:  2013-02-11       Impact factor: 3.876

10.  Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Marilia C O Sprandel; Whady A Hueb; Alexandre Segre; José A F Ramires; Roberto Kalil-Filho; Raul C Maranhão
Journal:  Cardiovasc Diabetol       Date:  2015-08-14       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.